Intralesional 5-Fluorouracil in the Treatment of Lower Leg Squamous Cell Carcinoma

J Drugs Dermatol. 2018 Nov 1;17(11):1241-1243.

Abstract

Non-melanoma skin cancer (NMSC) is the most commonly diagnosed cancer in the United States.1,2 There are different treatment modalities for non-melanoma skin cancer, that include surgical excision, radiation therapy, cryotherapy, electrodessication and curettage, photodynamic therapy, and topical chemotherapy. Intralesional injection with 5-fluorouracil is a treatment modality that is not used often, perhaps due to not much research available to its effectiveness or established treatment recommendations. We report a case of a patient with multiple lesions of cutaneous squamous cell carcinoma on the lower extremities treated successfully with intralesional 5- fluorouracil.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Biopsy
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Female
  • Fluorouracil / administration & dosage*
  • Humans
  • Injections, Intralesional*
  • Leg
  • Skin / pathology
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil